Literature DB >> 12626570

Human IgG2 can form covalent dimers.

Esther M Yoo1, Letitia A Wims, Lisa A Chan, Sherie L Morrison.   

Abstract

Unlike IgA and IgM, IgG has not yet been shown to form covalent polymers. However in the presence of specific Ag, murine IgG3 has been shown to polymerize through noncovalent interactions. In contrast to the noncovalent oligomers found with murine IgG3, we have detected covalent dimers in three different recombinant human IgG2 Abs produced in myeloma cells. Both IgG2,kappa and IgG2,lambda can form dimers. In addition, analysis of pooled human gamma globulin and several normal sera revealed the presence of IgG2 dimers. The IgG2 dimers are in contrast to the noncovalent IgG dimers found in pooled sera of multiple donors resulting from idiotype/anti-idiotype (Id/anti-Id) interactions. Cyanogen bromide cleavage analysis suggests that one or more Cys residues in the gamma 2 hinge are involved in dimer assembly. The potential role of IgG2 dimers in immunity against carbohydrate Ags is discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12626570     DOI: 10.4049/jimmunol.170.6.3134

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  Relative stabilities of IgG1 and IgG4 Fab domains: influence of the light-heavy interchain disulfide bond architecture.

Authors:  James T Heads; Ralph Adams; Lena E D'Hooghe; Matt J T Page; David P Humphreys; Andrew G Popplewell; Alastair D Lawson; Alistair J Henry
Journal:  Protein Sci       Date:  2012-08-09       Impact factor: 6.725

Review 2.  Stability of IgG isotypes in serum.

Authors:  Ivan R Correia
Journal:  MAbs       Date:  2010-05-16       Impact factor: 5.857

3.  A peptide mimotope of type 8 pneumococcal capsular polysaccharide induces a protective immune response in mice.

Authors:  Ulrike K Buchwald; Andrew Lees; Michael Steinitz; Liise-Anne Pirofski
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

4.  Effects of subclass change on the structural stability of chimeric, humanized, and human antibodies under thermal stress.

Authors:  Takahiko Ito; Kouhei Tsumoto
Journal:  Protein Sci       Date:  2013-09-30       Impact factor: 6.725

Review 5.  B-1 lymphocytes in mice and nonhuman primates.

Authors:  Karen M Haas
Journal:  Ann N Y Acad Sci       Date:  2015-04-30       Impact factor: 5.691

6.  Antagonist properties of monoclonal antibodies targeting human CD28: role of valency and the heavy-chain constant domain.

Authors:  Caroline Mary; Flora Coulon; Nicolas Poirier; Nahzli Dilek; Bernard Martinet; Gilles Blancho; Bernard Vanhove
Journal:  MAbs       Date:  2012-12-05       Impact factor: 5.857

7.  Disulfide scrambling in IgG2 monoclonal antibodies: insights from molecular dynamics simulations.

Authors:  Xiaoling Wang; Sandeep Kumar; Satish K Singh
Journal:  Pharm Res       Date:  2011-06-14       Impact factor: 4.200

8.  Immunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic mice.

Authors:  Robert W Maitta; Kausik Datta; Andrew Lees; Shelley Sims Belouski; Liise-anne Pirofski
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

9.  Viremic HIV Controllers Exhibit High Plasmacytoid Dendritic Cell-Reactive Opsonophagocytic IgG Antibody Responses against HIV-1 p24 Associated with Greater Antibody Isotype Diversification.

Authors:  M Christian Tjiam; James P A Taylor; Mazmah A Morshidi; Lucy Sariputra; Sally Burrows; Jeffrey N Martin; Steven G Deeks; Dino B A Tan; Silvia Lee; Sonia Fernandez; Martyn A French
Journal:  J Immunol       Date:  2015-04-24       Impact factor: 5.422

10.  Human Fc receptor-like 5 binds intact IgG via mechanisms distinct from those of Fc receptors.

Authors:  Andrea Franco; Bazarragchaa Damdinsuren; Tomoko Ise; Jessica Dement-Brown; Huifang Li; Satoshi Nagata; Mate Tolnay
Journal:  J Immunol       Date:  2013-04-24       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.